Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 2 Thyroid cancer, follicular 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thyroid Cancer, Papillary 1 Stomach Neoplasms 1 Recurrence 1 Neoplastic Cells, Circulating 1 Neoplasm Metastasis 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Disease 1 Colorectal Neoplasms 1 Carcinoma, Medullary 1 Adrenocortical Carcinoma 1 Adenocarcinoma of Lung 1

Interventions

Fluorouracil 19 Oxaliplatin 17 Capecitabine 16 Leucovorin 14 Cisplatin 12 Irinotecan 11 Gemcitabine 11 Drug Therapy 11 Bevacizumab 10 Radiosurgery 9 Cetuximab 9 pembrolizumab 8 Docetaxel 8 Everolimus 7 spartalizumab 6 Sunitinib 6 Radiotherapy 6 Paclitaxel 6 Neoadjuvant Therapy 6 Trastuzumab 5 S 1 (combination) 5 Nivolumab 5 Immunotherapy 5 Immune Checkpoint Inhibitors 5 Cyclophosphamide 5 Chemotherapy, Adjuvant 5 Carboplatin 5 palbociclib 4 manganese chloride 4 Surgical Procedures, Operative 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasm Metastasis × Lymph Node Excision × Clear all

NCT03230201 2017-08-08

UTUC

Peking University First Hospital

Phase NA Unknown

Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡